TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2025)
TELA Bio has reported Other Non-Current Liabilities over the past 8 years, most recently at $1.5 million for Q4 2025.
- Quarterly results put Other Non-Current Liabilities at $1.5 million for Q4 2025, up 6.26% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 6.26% YoY), and the annual figure for FY2025 was $1.5 million, up 6.26%.
- Other Non-Current Liabilities for Q4 2025 was $1.5 million at TELA Bio, down from $1.6 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for TELA hit a ceiling of $1.7 million in Q4 2023 and a floor of $8000.0 in Q1 2021.
- Median Other Non-Current Liabilities over the past 5 years was $1.3 million (2022), compared with a mean of $1.2 million.
- Biggest five-year swings in Other Non-Current Liabilities: surged 16925.0% in 2022 and later decreased 18.78% in 2025.
- TELA Bio's Other Non-Current Liabilities stood at $380000.0 in 2021, then soared by 223.95% to $1.2 million in 2022, then surged by 36.88% to $1.7 million in 2023, then fell by 17.51% to $1.4 million in 2024, then grew by 6.26% to $1.5 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $1.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.